Thu, October 19, 2023
Wed, October 18, 2023
Tue, October 17, 2023
Mon, October 16, 2023
Sun, October 15, 2023
Fri, October 13, 2023

Ashwani Verma Initiated (ACAD) at Strong Buy and Held Target at $33 on, Oct 17th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-33-on-oct-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ashwani Verma of UBS, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy and Held Target at $33 on, Oct 17th, 2023.

Ashwani has made no other calls on ACAD in the last 4 months.



There are 10 other peers that have a rating on ACAD. Out of the 10 peers that are also analyzing ACAD, 4 agree with Ashwani's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Julio Romero of "JP Morgan" Maintained at Hold with Increased Target to $29 on, Monday, August 7th, 2023
  • Jay Olson of "Oppenheimer" Reiterated at Hold and Held Target at $25 on, Thursday, August 3rd, 2023
  • Jeffrey Hung of "Morgan Stanley" Reiterated at Hold and Held Target at $30 on, Thursday, August 3rd, 2023
  • Neena Bitritto-Garg of "Citigroup" Maintained at Hold with Increased Target to $27 on, Friday, July 14th, 2023


These are the ratings of the 6 analyists that currently disagree with Ashwani


  • Tessa Romero of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $32 on, Tuesday, October 10th, 2023
  • Sarah James of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $42 on, Tuesday, August 22nd, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $38 on, Thursday, August 3rd, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $33 on, Thursday, August 3rd, 2023
  • Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $33 on, Friday, July 14th, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $39 on, Friday, July 14th, 2023

Publication Contributing Sources